EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+22.83%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$3.61B
AUM Growth
+$682M
(+23%)
Cap. Flow
+$165M
Cap. Flow
% of AUM
4.58%
Top 10 Holdings %
Top 10 Hldgs %
17.47%
Holding
954
New
83
Increased
179
Reduced
131
Closed
34
Top Buys
| 1 |
Biogen
BIIB
|
$35.3M |
| 2 |
Signet Jewelers
SIG
|
$13.5M |
| 3 |
Microsoft
MSFT
|
$12.7M |
| 4 |
Silicon Motion
SIMO
|
$11M |
| 5 |
TJX Companies
TJX
|
$11M |
Top Sells
| 1 |
Darden Restaurants
DRI
|
$27.2M |
| 2 |
Tapestry
TPR
|
$15.7M |
| 3 |
Ameriprise Financial
AMP
|
$12.6M |
| 4 |
Abbott
ABT
|
$9.4M |
| 5 |
Denali Therapeutics
DNLI
|
$9.37M |
Sector Composition
| 1 | Technology | 27.61% |
| 2 | Healthcare | 21.59% |
| 3 | Consumer Discretionary | 15.04% |
| 4 | Industrials | 8.92% |
| 5 | Financials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Diageo
DEO
$61.3B
| $3.31M | 0.09% |
20,442
| – | – |
|
202
iShares MSCI KLD 400 Social ETF
DSI
$4.81B
| $3.29M | 0.09% |
46,352
-80
| -0.2% | -$5.68K |
|
|
BMY.RT
203
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $3.29M | 0.09% |
2,425,220
+500,000
| +26% | +$678K |
|
204
Synopsys
SNPS
$111B
| $3.27M | 0.09% |
12,754
+1,053
| +9% | +$270K |
|
|
BPMC
205
DELISTED
Blueprint Medicines
BPMC
| $3.22M | 0.09% |
27,600
-25,100
| -48% | -$2.93M |
|
206
Exxon Mobil
XOM
$466B
| $3.22M | 0.09% |
77,963
+33,227
| +74% | +$1.37M |
|
207
Nutanix
NTNX
$18.7B
| $3.19M | 0.09% |
+100,000
| New | +$3.19M |
|
208
Kellanova
K
$27.8B
| $3.18M | 0.09% |
54,422
+15,017
| +38% | +$878K |
|
209
Chevron
CVX
$310B
| $3.17M | 0.09% |
37,412
+18,180
| +95% | +$1.54M |
|
210
NetApp
NTAP
$23.7B
| $3.14M | 0.09% |
48,200
+30,900
| +179% | +$2.01M |
|
211
Danaher
DHR
$143B
| $3.12M | 0.09% |
15,804
+15,411
| +3,921% | +$3.04M |
|
|
KDNY
212
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $3.1M | 0.09% |
190,669
-16,001
| -8% | -$261K |
|
213
Williams Companies
WMB
$69.9B
| $3.09M | 0.09% |
153,900
+4,900
| +3% | +$98.4K |
|
|
ONC
214
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $3.06M | 0.08% |
12,500
-500
| -4% | -$123K |
|
|
AYX
215
DELISTED
Alteryx, Inc.
AYX
| $3.06M | 0.08% |
+25,000
| New | +$3.06M |
|
216
Iovance Biotherapeutics
IOVA
$901M
| $3.05M | 0.08% |
64,000
+21,000
| +49% | +$1,000K |
|
217
Dow Inc
DOW
$17.4B
| $3.03M | 0.08% |
55,700
-22,700
| -29% | -$1.23M |
|
218
General Mills
GIS
$27B
| $3.02M | 0.08% |
51,100
+15,300
| +43% | +$905K |
|
219
Q32 Bio
QTTB
$20.4M
| $3.01M | 0.08% |
14,306
+4,278
| +43% | +$901K |
|
220
International Paper
IP
$25.7B
| $3.01M | 0.08% |
+64,838
| New | +$3.01M |
|
221
Kimberly-Clark
KMB
$43.1B
| $3M | 0.08% |
22,350
+22,200
| +14,800% | +$2.98M |
|
222
Amicus Therapeutics
FOLD
$2.46B
| $2.99M | 0.08% |
132,000
-26,600
| -17% | -$603K |
|
223
Ionis Pharmaceuticals
IONS
$9.76B
| $2.94M | 0.08% |
51,500
-6,500
| -11% | -$371K |
|
224
VF Corp
VFC
$5.86B
| $2.93M | 0.08% |
34,600
-7,500
| -18% | -$636K |
|
225
Consolidated Edison
ED
$35.4B
| $2.92M | 0.08% |
41,300
+10,000
| +32% | +$708K |
|